The world is seeing an escalation of obesity due to energy-sparing technology, sugary drinks, packaged or fast food, and the…
McAlinden Research PartnersMarch 25, 2019
Startups are experimenting with the gene-editing technology CRISPR to make lab-grown meat a commercially viable reality. Meanwhile, the first commercially…
McAlinden Research PartnersMarch 18, 2019
Investors seeking a more defensive positioning have rushed into health care stocks in recent months, as hype about the aging…
McAlinden Research PartnersFebruary 4, 2019
Just as Uber and Lyft connect riders to drivers via technology, so too are telehealth companies connecting patients and doctors…
McAlinden Research PartnersJanuary 14, 2019
“CRISPR babies” have been on everyone’s lips since news broke last week that Chinese scientists claimed they had produced the…
McAlinden Research PartnersDecember 4, 2018
The Trump Administration may finally be taking serious action against the pharmaceutical industry in a bid to cut down heavily…
McAlinden Research PartnersOctober 30, 2018
CRISPR stocks have gotten battered in the second half of the year, yet the precision gene-editing technology is proving to…
McAlinden Research PartnersOctober 25, 2018
The administration has, thus far, taken measured action against drug prices since President Trump announced his “blueprint” to tackle high…
McAlinden Research PartnersAugust 15, 2018
While the US meat industry has lately been racked by trade war fallout, resulting in huge surpluses, domestic demand is…
McAlinden Research PartnersAugust 9, 2018
